<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Научные результаты биомедицинских исследований</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2658-6533-2019-5-4-0-3</article-id><article-id pub-id-type="publisher-id">1835</article-id><article-categories><subj-group subj-group-type="heading"><subject>Генетика</subject></subj-group></article-categories><title-group><article-title>Эффект полиморфизма генов &lt;em&gt;IL10&lt;/em&gt; (rs1800872) и &lt;em&gt;CXCL10&lt;/em&gt; (rs4386624, rs4256246) в развитии инфекционных заболеваний вирусной и бактериальной природы</article-title><trans-title-group xml:lang="en"><trans-title>Effect of &lt;em&gt;IL10&lt;/em&gt; (rs1800872) and &lt;em&gt;CXCL10&lt;/em&gt; (rs4386624, rs4256246) genes polymorphism in the development of viral and bacterial infectious diseases</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Гончарова</surname><given-names>Ирина Александровна</given-names></name><name xml:lang="en"><surname>Goncharova</surname><given-names>Irina A.</given-names></name></name-alternatives><email>irina.goncharova@medgenetics.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Брагина</surname><given-names>Елена Юрьевна</given-names></name><name xml:lang="en"><surname>Bragina</surname><given-names>Elena Yu.</given-names></name></name-alternatives><email>elena.bragina@medgenetics.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Жалсанова</surname><given-names>Ирина Жаргаловна</given-names></name><name xml:lang="en"><surname>Zhalsanova</surname><given-names>Irina Z.</given-names></name></name-alternatives><email>irina.zhalsanova@medgenetics.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Бабушкина</surname><given-names>Надежда Петровна</given-names></name><name xml:lang="en"><surname>Babushkina</surname><given-names>Nadezhda P.</given-names></name></name-alternatives><email>nad.babushkina@medgenetics.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Гомбоева</surname><given-names>Дэнсэма Евгеньевна</given-names></name><name xml:lang="en"><surname>Gomboeva</surname><given-names>Densema E.</given-names></name></name-alternatives><email>gomboeva.densema@medgenetics.ru</email></contrib></contrib-group><pub-date pub-type="epub"><year>2019</year></pub-date><volume>5</volume><issue>4</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2019/4/НР_БМИ._2019_Том_5__4_Ст._3.pdf" /><abstract xml:lang="ru"><p>Актуальность: Контакт человека с патогенными микроорганизмами является необходимым, но недостаточным условием для развития болезни. Иммунный ответ на внедрение патогена в значительной степени контролируется генетическими факторами, исследование которых актуально в связи с высокой распространенностью инфекционных заболеваний, таких как туберкулез (ТБ) и вирусный гепатит С (ХВГС). Цель исследования: Изучить ассоциации полиморфных вариантов генов противоинфекционного иммунного ответа IL10 (rs1800872) и CXCL10 (rs4386624, rs4256246) в развитии инфекционных заболеваний разной этиологии. Материалы и методы: Генотипирование выполнено у пациентов с туберкулезом легких (n=304), вирусным гепатитом С (n=184) и относительно здоровых индивидов (n=255) путем реал-тайм ПЦР с&amp;nbsp; помощью&amp;nbsp; TaqMan-зондов и рестрикционного анализа. Оценку ассоциаций осуществляли с помощью критерия &amp;chi;2 или точного критерия Фишера. Различия считались значимыми при р&amp;lt;0,05. Результаты: Полиморфизм генов IL10 (rs1800872) и CXCL10 (rs4256264) ассоциирован с развитием инфекционных заболеваний различной этиологии. Генотипы &amp;laquo;АС&amp;raquo; и &amp;laquo;АА&amp;raquo; гена IL10 (rs1800872) являются &amp;laquo;неблагоприятными&amp;raquo; в отношении индукции иммунного ответа на воздействие микобактерии туберкулеза и вируса гепатита С. Частота встречаемости данных генотипов выше в группах больных (ХВГС &amp;ndash; 43,1%,&amp;nbsp; р=0,033; ТБ &amp;ndash; 44,0% р=0,013) по сравнению с контролем (32,2%). Генотипы &amp;laquo;АG&amp;raquo; и &amp;laquo;GG&amp;raquo; гена CXCL10 (rs4256264) так же ассоциированы с изученными&amp;nbsp; инфекционными заболеваниями и распространены с большей частотой в группах больных (ХВГС &amp;ndash; 100%, р=0,0079; ТБ &amp;ndash; 99,3%, р=0,023) по сравнению с контролем (96,2%). Заключение: Функционально значимые варианты в генах IL10 (rs1800872) и CXCL10 (rs4256264) являются перспективными прогностическими маркерами недостаточности иммунного ответа при воздействии инфекционных агентов бактериальной и вирусной природы.</p></abstract><trans-abstract xml:lang="en"><p>Background: Host-pathogenic interaction is a necessary but not sufficient precondition for the development of the disease. The immune response to the introduction of pathogen is largely controlled by genetic factors, whose study is relevant because infectious diseases, such as tuberculosis (TB) and chronic viral hepatitis C (HCV) are highly prevalent in the world. The aim of the study: To study the associations of polymorphic variants of the IL10 (rs1800872) and CXCL10 (rs4386624, rs4256246) genes of the anti-infectious immune response in the development of infectious diseases of various etiologies. Materials and methods: Genotyping was performed in patients with pulmonary tuberculosis (n = 304), viral hepatitis C (n = 184) and relatively healthy individuals (n = 255) by real-time PCR using TaqMan probes and restriction analysis. The associations were evaluated using the &amp;chi;2 test or the Fisher&amp;#39;s exact test. The significance threshold was set at p&amp;lt;0.05. Results: The polymorphism of genes IL10 (rs1800872) and CXCL10 (rs4256264) is associated with infectious diseases of various etiologies. The &amp;ldquo;AC&amp;rdquo; and &amp;ldquo;AA&amp;rdquo; genotypes of the IL10 gene (rs1800872) are &amp;ldquo;adverse&amp;rdquo; to the induction of the immune response to the effects of mycobacterium tuberculosis and the hepatitis C virus. The frequency of these genotypes is higher in patients (HCV &amp;ndash; 43.1%, p = 0.033; TB &amp;ndash; 44.0% p = 0.013) compared with the control (32.2%). The &amp;ldquo;AG&amp;rdquo; and &amp;ldquo;GG&amp;rdquo; genotypes of the CXCL10 gene (rs4256264) are also associated with infectious diseases and are more common in the patients (HCV &amp;ndash; 100%, p = 0.0079; TB &amp;ndash; 99.3%, p = 0.023) compared with control (96.2%). Conclusion: Functionally significant polymorphisms in the IL10 (rs1800872) and CXCL10 (rs4256264) genes are promising prognostic markers of deficiency of the immune response to infection of bacterial and viral etiology.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>туберкулез</kwd><kwd>вирусный гепатит С</kwd><kwd>полиморфизм генов</kwd><kwd>IL10</kwd><kwd>CXCL10</kwd></kwd-group><kwd-group xml:lang="en"><kwd>tuberculosis</kwd><kwd>viral hepatitis С</kwd><kwd>genes polymorphism</kwd><kwd>IL10</kwd><kwd>CXCL10</kwd></kwd-group></article-meta></front><back><ack><p>Работа проведена в рамках выполнения Государственного задания Министерства науки и высшего образования № 075-00603-19-00 (Федеральное государственное бюджетное научное учреждение &amp;laquo;Томский национальный исследовательский медицинский центр Российской академии наук&amp;raquo;). </p></ack><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Мезенцева В.А., Стаханов М.В., Захарова М.В. Цитокины как маркеры развития инфильтративного туберкулеза легких // Инфекция и иммунитет. 2011. Т. 1. N. 4. C. 367-372.</mixed-citation></ref><ref id="B2"><mixed-citation>T Cell-Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection / L. Moreira-Teixeira [et al.] // J. Immunol. 2017. Vol. 199(2). P. 613-623. DOI: 10.4049/jimmunol.1601340</mixed-citation></ref><ref id="B3"><mixed-citation>Genetic variants in IL-6 and IL-10 genes and susceptibility to hepatocellular carcinoma in HCV infected patients / I. Sghaier [et al.] // Cytokine. 2017. N. 89. P. 62-67. DOI: 10.1016/j.cyto.2016.10.004</mixed-citation></ref><ref id="B4"><mixed-citation>Circulating levels of CXCL11 and CXCL12 are biomarkers of cirrhosis in patients with chronic hepatitis C infection / A. Chalin [et al.] // Cytokine. 2019. N. 117. P. 72-78. DOI: 10.1016/j.cyto.2019.02.006</mixed-citation></ref><ref id="B5"><mixed-citation>Bhattacharyya C., Majumder P.P., Pandit B. CXCL10 is overexpressed in active tuberculosis patients compared to M. tuberculosis-exposed household contacts // Tuberculosis (Edinb). 2018. N. 109. P. 8-16. DOI: 10.1016/j.tube.2018.01.005</mixed-citation></ref><ref id="B6"><mixed-citation>Анализ генов цитокиновой сети в развитии &amp;quot;обратной&amp;quot; коморбидности для бронхиальной астмы и туберкулеза / Е.Ю. Брагина [и др.] // Медицинская генетика. 2017. Т. 16. N 1. С. 20-24.</mixed-citation></ref><ref id="B7"><mixed-citation>Hedrich C.M., Bream J.H. Cell type-specific regulation of IL-10 expression in inflammation and disease // Immunol Res. 2010. Vol. 47(1-3). P. 185-206. DOI: 10.1007/s12026-009-8150-5</mixed-citation></ref><ref id="B8"><mixed-citation>Swiątek B.J. Is interleukin-10 gene polymorphism a predictive marker in HCV infection? // Cytokine Growth Factor Rev. 2012. Vol. 23(1-2). P. 47-59. DOI: 10.1016/j.cytogfr.2012.01.005</mixed-citation></ref><ref id="B9"><mixed-citation>A hallmark of balancing selection is present at the promoter region of interleukin 10 / J.N. Wilson [et al.] // Genes Immun. 2006. Vol. 7(8). P. 680-3. DOI: 10.1038/sj.gene.6364336</mixed-citation></ref><ref id="B10"><mixed-citation>Interleukin 10 (IL-10) influences autoimmune response in primary Sj&amp;ouml;gren&amp;#39;s syndrome and is linked to IL-10 gene polymorphism / J.M. Anaya [et al.] // J. Rheumatol. 2002. Vol. 29(9). P. 1874-6.</mixed-citation></ref><ref id="B11"><mixed-citation>gene polymorphisms are associated with asthma phenotypes in children / H. Lyon [et al.] // Genet Epidemiol. 2004. Vol. 26(2). P. 155-65. DOI: https://doi.org/10.1002/gepi.10298</mixed-citation></ref><ref id="B12"><mixed-citation>Polymorphisms and Tuberculosis Susceptibility: An Updated Meta-Analysis / Z. Ke [et al.] // Yonsei Med J. 2015. Vol. 56(5). P. 1274-1287. DOI: https://doi.org/10.3349/ymj.2015.56.5.1274&amp;nbsp;</mixed-citation></ref><ref id="B13"><mixed-citation>-1082 A&amp;gt;G (rs1800896) polymorphism confers susceptibility to pulmonary tuberculosis in Caucasians but not in Asians and Africans: a meta-analysis / M.Y. Areeshi [et al.] // Bioscience Reports. 2017. N. 37. P. BSR20170240. DOI: https://doi.org/10.1042/BSR20170240</mixed-citation></ref><ref id="B14"><mixed-citation>Interleukin-10 gene polymorphisms in association with susceptibility to chronic hepatitis C virus infection: a meta-analysis study / L.Z. Zhang [et al.] // Arch Virol. 2010. Vol. 155(11). P. 1839-42. DOI: 10.1007/s00705-010-0757-2</mixed-citation></ref><ref id="B15"><mixed-citation>and IL10R -1087 polymorphisms are protective for chronic genotype 1 HCV infection and predictors of response to interferon-based therapy in an East-Central European cohort / A. P&amp;aacute;r [et al.] // BMC Res Notes. 2014. N 8. P. 7-12. DOI: 10.1186/1756-0500-7-12</mixed-citation></ref><ref id="B16"><mixed-citation>Effect of interleukin-10 gene promoter polymorphisms -1082 G/A and -592 C/A on response to therapy in children and adolescents with chronic hepatitis C virus infection / H.M. El-Karaksy [et al.] // Hum Immunol. 2016 Vol. 77(12). P. 1248-1253. DOI: 10.1016/j.humimm.2016.09.005</mixed-citation></ref><ref id="B17"><mixed-citation>Noureldin AK5 Interleukin-10 and Interferon Gamma Gene Polymorphisms and Hepatitis C Virus-Related Liver Cirrhosis Risk / A. Sheneef [et al.] // J. Interferon Cytokine Res. 2017. Vol. 37(4) P. 175-180. DOI: 10.1089/jir.2016.0106</mixed-citation></ref><ref id="B18"><mixed-citation>A study of association between regulatory polymorphism in the IL-10 gene promoter region and acute viral hepatitis, and acute liver failure / G. Maurya [et al.] // Indian J. Gastroenterol. 2018 Vol. 37(4). P. 293-298. DOI: 10.1007/s12664-018-0858-5</mixed-citation></ref><ref id="B19"><mixed-citation>Association between IL-10 gene promoter polymorphism and hepatitis B viral infection in an Egyptian population / R.M. Talaat [et al.]// Biochem Genet. 2014. Vol. 52(9-10). P. 387-402. DOI: 10.1007/s10528-014-9655-8</mixed-citation></ref><ref id="B20"><mixed-citation>Interleukin-10 promoter gene polymorphisms are associated with the first major depressive episode in chronic hepatitis C patients / L.R.D. Cunha [et al.] // Clin Res Hepatol Gastroenterol. 2019. Vol. 43(4). P. 417-426. DOI: 10.1016/j.clinre.2018.11.015</mixed-citation></ref><ref id="B21"><mixed-citation>Interplay of DDP4 and IP-10 as a Potential Mechanism for Cell Recruitment to Tuberculosis Lesions / T. Blauenfeldt [et al.] // Front Immunol.2018. N 9. P. 1456. DOI: https://doi.org/10.3389/fimmu.2018.01456</mixed-citation></ref><ref id="B22"><mixed-citation>Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C? / S.M. Ferrari [et al.] // J. Immunol Res. 2019. N 2019. P. 5878960. DOI: 10.1155/2019/5878960</mixed-citation></ref><ref id="B23"><mixed-citation>Interferon-&amp;gamma;-inducible protein-10 in chronic hepatitis C: Correlations with insulin resistance, histological features &amp;amp; sustained virological response / D. Crisan [et al.] // Indian J. Med Res. 2017. Vol. 145(4). P. 543-550. DOI: 10.4103/ijmr.IJMR_1410_14</mixed-citation></ref><ref id="B24"><mixed-citation>Regulatory polymorphism of CXCL10 rs1439490 in seronegative occult hepatitis C virus infection / X. Wang [et al.] // World J. Gastroenterol. 2018. Vol. 24(20). P. 2191-2202. DOI: 10.3748/wjg.v24.i20.2191</mixed-citation></ref><ref id="B25"><mixed-citation>Genetic association between a chemokine gene CXCL-10 (IP-10, interferon gamma inducible protein 10) and susceptibility to tuberculosis / N.L. Tang [et al.] // Clin Chim Acta.2009. Vol. 406(1-2). P. 98-102. DOI: 10.1016/j.cca.2009.06.006</mixed-citation></ref><ref id="B26"><mixed-citation>RNAseq Profiling of Leukocyte Populations in Zebrafish Larvae Reveals a cxcl11 Chemokine Gene as a Marker of Macrophage Polarization During Mycobacterial Infection / J. Rougeot [et al.] // Front Immunol. 2019. N 10. P. 832. DOI: 10.3389/fimmu.2019.00832</mixed-citation></ref><ref id="B27"><mixed-citation>Nucleoporin 54 contributes to homologous recombination repair and post-replicative DNA Integrity / G. Rodriguez-Berriguete [et al.] // Nucleic Acids Research. 2018. Vol. 46(15). P. 7731-7746. DOI: 10.1093/nar/gky569</mixed-citation></ref><ref id="B28"><mixed-citation>Generation and comprehensive analysis of an influenza virus polymerase cellular interaction network / L. Tafforeau [et al.] // J. Virol. 2011. Vol. 85(24). P. 13010-8. DOI: 10.1128/JVI.02651-10</mixed-citation></ref><ref id="B29"><mixed-citation>Mono-ADP-ribosyltransferases in human monocytes: regulation by lipopolysaccharide / A. Grahnert [et al.] // Biochem J. 2002. Vol. 362(Pt 3). P. 717-23. DOI: 10.1042/0264-6021:3620717</mixed-citation></ref><ref id="B30"><mixed-citation>Expression and selective up-regulation of toxin-related mono ADP-ribosyltransferases by pathogen-associated molecular patterns in alveolar epithelial cells / E. Balducci [et al.] // FEBS Lett. 2007. Vol. 581(22). P. 4199-204. DOI: https://doi.org/10.1016/j.febslet.2007.07.061</mixed-citation></ref></ref-list></back></article>